This study establishes PCP4 downregulation as a pivotal event in PCa progression, especially the CRPC progression, disrupting Ca2+ homeostasis to amplify CAMKK2/AMPK/AR signaling. The gene discussed is PCP4; the disease is posterior cortical atrophy.